Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review

Bee Kim Tan,1 Ping Chong Bee,2 Siew Siang Chua,1 Li-Chia Chen3 1School of Pharmacy, Faculty of Health and Medical Sciences, Taylor’s University, Subang Jaya, Selangor, 47500, Malaysia; 2Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia; 3Centre for Phar...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tan BK, Bee PC, Chua SS, Chen LC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	medication adherence tyrosine kinase inhibitors chronic myeloid leukemia systematic review complex interventions Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/ce5ba4cf6fb04fad81eb15dbe2b7a408
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ce5ba4cf6fb04fad81eb15dbe2b7a408
record_format	dspace
spelling	oai:doaj.org-article:ce5ba4cf6fb04fad81eb15dbe2b7a4082021-11-18T19:40:25ZMonitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review1177-889Xhttps://doaj.org/article/ce5ba4cf6fb04fad81eb15dbe2b7a4082021-11-01T00:00:00Zhttps://www.dovepress.com/monitoring-and-improving-adherence-to-tyrosine-kinase-inhibitors-in-pa-peer-reviewed-fulltext-article-PPAhttps://doaj.org/toc/1177-889XBee Kim Tan,1 Ping Chong Bee,2 Siew Siang Chua,1 Li-Chia Chen3 1School of Pharmacy, Faculty of Health and Medical Sciences, Taylor’s University, Subang Jaya, Selangor, 47500, Malaysia; 2Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia; 3Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UKCorrespondence: Bee Kim TanSchool of Pharmacy, Faculty of Health and Medical Sciences, Taylor’s University, Subang Jaya, Selangor, 47500, MalaysiaTel +6 03 5629 5000Email beekim.tan@taylors.edu.myPurpose: Suboptimal adherence to tyrosine kinase inhibitors (TKIs) is a widely recognized issue compromising the disease control and survival of patients with chronic myeloid leukemia (CML). A recently published review by Heiney et al reported inconclusive findings on the effects of a broad range of adherence enhancing interventions. The current systematic review aimed to identify studies that evaluated adherence-enhancing interventions implemented by healthcare professionals and determine their effect on CML patients’ medication adherence and clinical outcomes.Methods: A systematic literature search was performed in 5 databases for articles published between 2002 and 2021. Studies that compared adherence enhancing interventions implemented by healthcare professionals with a comparison group were included. Relevant data on study characteristics were extracted. Medication adherence and clinical outcomes between intervention and control arms were compared.Results: Nine studies were included in two randomised controlled trials, four cohort studies, and three before-and-after comparison studies. All the included studies incorporated complex interventions, including intensive education or consultation with pharmacists, nurses or multidisciplinary team, in combination with one or more other strategies such as structured follow-up, written materials or video, psychotherapy, medication reminder or treatment diary, with the overall goal of monitoring and improving TKI adherence. Most (7 out of 9) studies demonstrated significantly better adherence to TKIs in the intervention group than the comparison group. The relative proportion of participants who adhered to TKIs ranged from 1.22 to 2.42. The improvement in the rate of TKI doses taken/received ranged from 1.5% to 7.1%. Only one study showed a significant association between intervention and clinical outcomes, with a 22.6% higher major molecular response rate and improvement in 6 out of 20 subscales of health-related quality-of-life.Conclusion: Complex interventions delivered by healthcare professionals showed improvement in adherence to TKIs in CML patients. Further studies are required to clarify the cost-effectiveness of adherence-enhancing interventions.Keywords: medication adherence, tyrosine kinase inhibitors, chronic myeloid leukemia, systematic review, complex interventionsTan BKBee PCChua SSChen LCDove Medical Pressarticlemedication adherencetyrosine kinase inhibitorschronic myeloid leukemiasystematic reviewcomplex interventionsMedicine (General)R5-920ENPatient Preference and Adherence, Vol Volume 15, Pp 2563-2575 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	medication adherence tyrosine kinase inhibitors chronic myeloid leukemia systematic review complex interventions Medicine (General) R5-920
spellingShingle	medication adherence tyrosine kinase inhibitors chronic myeloid leukemia systematic review complex interventions Medicine (General) R5-920 Tan BK Bee PC Chua SS Chen LC Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review
description	Bee Kim Tan,1 Ping Chong Bee,2 Siew Siang Chua,1 Li-Chia Chen3 1School of Pharmacy, Faculty of Health and Medical Sciences, Taylor’s University, Subang Jaya, Selangor, 47500, Malaysia; 2Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia; 3Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UKCorrespondence: Bee Kim TanSchool of Pharmacy, Faculty of Health and Medical Sciences, Taylor’s University, Subang Jaya, Selangor, 47500, MalaysiaTel +6 03 5629 5000Email beekim.tan@taylors.edu.myPurpose: Suboptimal adherence to tyrosine kinase inhibitors (TKIs) is a widely recognized issue compromising the disease control and survival of patients with chronic myeloid leukemia (CML). A recently published review by Heiney et al reported inconclusive findings on the effects of a broad range of adherence enhancing interventions. The current systematic review aimed to identify studies that evaluated adherence-enhancing interventions implemented by healthcare professionals and determine their effect on CML patients’ medication adherence and clinical outcomes.Methods: A systematic literature search was performed in 5 databases for articles published between 2002 and 2021. Studies that compared adherence enhancing interventions implemented by healthcare professionals with a comparison group were included. Relevant data on study characteristics were extracted. Medication adherence and clinical outcomes between intervention and control arms were compared.Results: Nine studies were included in two randomised controlled trials, four cohort studies, and three before-and-after comparison studies. All the included studies incorporated complex interventions, including intensive education or consultation with pharmacists, nurses or multidisciplinary team, in combination with one or more other strategies such as structured follow-up, written materials or video, psychotherapy, medication reminder or treatment diary, with the overall goal of monitoring and improving TKI adherence. Most (7 out of 9) studies demonstrated significantly better adherence to TKIs in the intervention group than the comparison group. The relative proportion of participants who adhered to TKIs ranged from 1.22 to 2.42. The improvement in the rate of TKI doses taken/received ranged from 1.5% to 7.1%. Only one study showed a significant association between intervention and clinical outcomes, with a 22.6% higher major molecular response rate and improvement in 6 out of 20 subscales of health-related quality-of-life.Conclusion: Complex interventions delivered by healthcare professionals showed improvement in adherence to TKIs in CML patients. Further studies are required to clarify the cost-effectiveness of adherence-enhancing interventions.Keywords: medication adherence, tyrosine kinase inhibitors, chronic myeloid leukemia, systematic review, complex interventions
format	article
author	Tan BK Bee PC Chua SS Chen LC
author_facet	Tan BK Bee PC Chua SS Chen LC
author_sort	Tan BK
title	Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review
title_short	Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review
title_full	Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review
title_fullStr	Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review
title_full_unstemmed	Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review
title_sort	monitoring and improving adherence to tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a systematic review
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/ce5ba4cf6fb04fad81eb15dbe2b7a408
work_keys_str_mv	AT tanbk monitoringandimprovingadherencetotyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaasystematicreview AT beepc monitoringandimprovingadherencetotyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaasystematicreview AT chuass monitoringandimprovingadherencetotyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaasystematicreview AT chenlc monitoringandimprovingadherencetotyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaasystematicreview
_version_	1718420753983995904

Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review

Ejemplares similares